Truist Securities expressed confidence in its latest note that Merck will be able to navigate the upcoming Gardasil headwinds ...

Co., Inc. (NYSE:MRK), a global healthcare leader, finds itself at a crossroads as it navigates challenges in its China Gardasil business while capitalizing on opportunities in pulmonary arterial ...

Its shares are up by 11.6 ... day 1.60% higher. Cramer was exasperated: “Is Disney somehow a winner? I mean you see these things that are just up and you want to say, are you kidding?” Merck ...

The next major content drop for Call of Duty is here, as Treyarch has pushed out Black Ops 6 download version 1.068, which ...

Merck has traditionally eschewed large-scale M&A, but has been warming to the concept in recent years, with deals including its $11.5 billion takeover of Acceleron last year and its $2.75 billion ...

Merck & Co/MSD has agreed to buy Pandion for $1.85 billion, bolting on a pipeline of drugs for autoimmune and other immunological disorders headed by interleukin-2 (IL-2) based therapy PT-101.

Merck said its board authorized an additional $10 billion share repurchase authorization, which has no time limit for completion. The maker of medicines and vaccines has a market cap of $247.75 ...

Merck & Co., Inc. (NYSE:MRK) is a pharmaceutical company that has made waves with some of the most popular medicines in the world lately. The firm’s flagship drug is KEYTRUDA, which helps cancer ...

Kennedy Jr.'s secretary of the Department of Health and Human Services (HHS) confirmation hearing and how pharma stocks like Pfizer (PFE) and Merck (MRK) may be impacted: "There's been a lot of ...

Merck & Co., Inc. operates as a healthcare company ... a novel investigational PD-1/VEGF bispecific antibody from LaNova. The company also has a collaboration agreement with Eisai Co., Ltd ...